Source: Eur Respir J 2015; 46: 1529-1530
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
De Pampa, Bhuniya Sourin. The Rotterdam study: why fall in COPD?. Eur Respir J 2015; 46: 1529-1530

Member's Comments

No comment yet.

Related content which might interest you: GOLD classifications and mortality in COPD: The HUNT study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Prevalence and incidence of COPD: The Rotterdam study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 COPD symptoms/diagnoses and work exposure: A 20 years population-based survey Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Undiagnosed COPD: who is at risk, and does it matter? The Guangzhou biobank cohort study (GBCS) Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Smoking reduction and hospitalization from COPD: a Danish population study Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001 Prevalence of common diseases in COPD patients versus lung-healthy control subjects: Results from the German COSYCONET study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 Night time dyspnea in COPD: A study of a general population Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Impact of frailty on interpretability of spirometry: The Rotterdam study Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 The lifetime risk of developing COPD. The Rotterdam study Source: Annual Congress 2008 - Environmental risk factors for respiratory symptoms and COPD Year: 2008 Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important? Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 Pilot of a population cohort for the study of the natural history of COPD and OSAS: the pulsaib study Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Experience of work with patients with COPD Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals Year: 2013 Treatment of COPD in general practice: the COOPT study Source: Eur Respir J 2001; 18: Suppl. 33, 348s Year: 2001